JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2021. Vol. 66. № 3. P. 68–75
Е.S. Sukhikh1,2, L.G. Sukhikh2, A.V. Vertinsky1,2, P.V. Izhevsky3, I.N. Sheino3, V.V. Vertoukhova2
Analysis of the Physical and Radiobiological Equivalence of the Calculated
and Measured Dose Distributions for Prostate Stereotactic Radiotherapy
1Tomsk Regional Oncology Center, Tomsk, Russia
2National Research Tomsk Polytechnic University, Tomsk, Russia
3AI Burnasyan Federal Medical Biophysical Center Moscow, Russia
Contact person: Andrei Vladimirovich Vertinskii: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: Carrying out the analysis of the physical and radiobiological equivalence of dose distributions obtained during the planning of hypofractionated stereotactic radiation therapy of the prostate cancer and verification using a three-dimensional cylindrical dosimeter.
Material and Methods: Based on the anatomical data of twelve patients diagnosed with prostate carcinoma, stage T2N0M0 with low risk, plans were developed for stereotactic radiation therapy with volumetric modulates arc therapy (VMAT). The dose per fraction was 7,25 Gy for 5 fractions (total dose 36,25 Gy) with a normal photon energy of 10 MV. The developed plans were verified using a three-dimensional cylindrical ArcCHECK phantom. During the verification process, the three-dimensional dose distribution in the phantom was measured, based on which the values of the three-dimensional gamma index and the dose–volume histogram within each contoured anatomical structures were calculated with 3DVH software.
The gamma index value γ (3 %, 2 mm, GN) at a threshold equal to 20 % of the dose maximum of the plan and the percentage of coincidence of points at least 95 % was chosen as a criterion of physical convergence of the calculated and measured dose distribution according to the recommendations of AAPM TG-218. To analyze the radiobiological equivalence of the calculated and measured dose distribution, the local control probability (TCP) and normal tissue complication probability (NTCP) criteria were used based on the calculated and measured dose–volume histograms. Contours of the target (PTV) and the anterior wall of the rectum were used for the analysis. The approach based on the concept of equivalent uniform dose (EUD) by A. Niemierko was used to calculate the values of TCP/NTCP criteria.
Results: The results of physical convergence of plans for all patients on the contour of the whole body were higher than 95 % for the criteria γ (3 %, 2 mm, GN). The convergence along the PTV contour is in the range (75.5–95.2)%. The TCP and NTCP values obtained from the measured dose-volume histograms were higher than the planned values for all patients. It was found that the accelerator delivered a slightly higher dose to the PTV and the anterior wall of the rectum than originally planned.
Conclusion: The capabilities of modern dosimetric equipment allow us move to the verification of treatment plans based on the analysis of TCP / NTCP radiobiological equivalence, taking into account the individual characteristics of the patient and the capabilities of radiation therapy equipment.
Key words: 3D gamma analysis, dose-volume histogram, tumor control probability, normal tissue complication probability
For citation: Sukhikh ЕS, Sukhikh LG, Vertinsky AV, Izhevsky PV, Sheino IN, Vertoukhova VV. Analysis of the Physical and Radiobiological Equivalence of the Calculated and Measured Dose Distributions for Prostate Stereotactic Radiotherapy. Medical Radiology and Radiation Safety. 2021;66(3):68-75.
DOI: 10.12737/1024-6177-2021-66-3-68-75
References
- Lo SS, Teh. BS, Lu JJ, et al. Stereotactic Body Radiation Therapy. Berlin Heidelberg, Springer-Verlag, 2012. 434 p. https://doi.org/10.1007/978-3-642-25605-9.
- Ezzell GA, Burmeister JW, Dogan N, et al. IMRT Commissioning: Multiple Institution Planning and Dosimetry Comparisons. A Report from AAPM Task Group 119. Med. Phys. 2019;36 (XI):5359–5373.
- Smilowitz JB, Das IJ, Feygelman V, et al. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations— Megavoltage Photon and Electron Beams. J Appl Clin Med Phys. 2015,16(V):14-34. DOI: 10.1120/jacmp.v16i5.5768.
- Miftena M, Olch A, Mihailidis D. Tolerance Limits and Methodologies for IMRT Measurement-Based Verification QA: Recommendations of AAPM Task Group No.218. Med. Phys. 2018;45(IV):e53-83.
- Nelms BE, Opp D, Robinson J, et al. VMAT QA: Measurement-Guided 4D Dose Reconstruction on a Patient. Med. Phys. 2012;39(8):4228-4238.
- Olch AJ. Evaluation of the Accuracy of 3DVH Software Estimates of Dose to Virtual Ion Chamber and Film in Composite IMRT QA. Med. Phys. 2012;39(1):81-86.
- Вертинский А.В., Сухих Е.С., Сухих Л.Г. Верификация терапевтических планов с объёмной модуляцией интенсивности излучения // Медицинская физика. 2018. Т.78. №2. Т. 78. С. 12-20 [Vertinskiy AV, Sukhikh ES, Sukhikh LG. Verification of Therapeutic Plans with Volume Modulation of Radiation Intensity. Medical Physics. 2015;78(2):12-21 (In Russian)].
- Gay HA, Niemierko A. A Free Program for Calculating EUD-based NTCP and TCP in External Beam Radiotherapy. Phys Med. 2007;23(3-4):115-25. DOI: 10.1016/j.ejmp.2007.07.001.
- Paudel NR, Narayanasamy G, Han EY, et al. Dosimetric and Radiobiological Comparison for Quality Assurance of IMRT and VMAT Plans. Radiation Oncology Physics. 2017;18(5):237-244. https://doi.org/10.1002/acm2.12145.
- Sumida I, Yamaguchi H, Kizaki H. Novell Radiological Gamma Index for Evaluation of 3-Dimentional Predicted Dose Distribution. Int J Radiat Oncol Biol Phys. 2015;92(4):779-86. DOI: 10.1016/j.ijrobp.2015.02.041.
- Sukhikh ES, Sukhikh LG, Taletsky AV, et al. Influence of SBRT Fractionation on TCP and NTCP Estimations for Prostate Cancer. Physica Medica. 2019;62:41–46. DOI: https://doi.org/10.1016/ j.ejmp.2019.04.017.
- Levegrün S, Jackson A, Zelefsky M, et al. Risk Group Dependence of Dose-Response for Biopsy Outcome after Three-Dimensional Conformal Radiation Therapy of Prostate Cancer. Radiother Oncol. 2002;63(1):11–26. https://doi.org/10.1016/ S0167-8140(02)00062-2.
- Dasu A, Dasu I. Prostate Alpha/Beta Revisited an Analysis of Clinical Results from 14168 Patients. Acta Oncol. 2012;51(8):963–74. https://doi.org/10.3109/0284186X.2012. 719635.
- Cheung R, Tucker SL, Lee AK, et al. Dose-Response Characterictics of Low- and Intermediate-Risk Prosate Cancer Treated with External Beam Radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61(4):993-1002.
- Rana S, Cheng C, Zhao L, et al. Dosimetric and Radiobiological Impact of Intensity Modulated Proton Therapy and Rapidarc Planning for High-Risk Prostate Cancer with Seminal Vesicles. J Med Radiat Sci. 2017;64(1):18–24. https://doi.org/10.1002/ jmrs.175.
- Deasy J, Mayo C, Orton C. Treatment Planning Evaluation and Optimization should be Biologically and not Dose / Volume Based. Med Phys. 2015;42(6):2753-6. DOI: 10.1118/1.4916670
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 23.12.2020.
Accepted for publication: 20.01.2021.